A Phase 1, Open-label, 1-Sequence Crossover, Drug-drug Interaction Study to Assess the Effect of Repeated Doses of BPN14770 on the Pharmacokinetics of Rosuvastatin in Healthy Adult Participants
Latest Information Update: 07 Jul 2025
At a glance
- Drugs Rosuvastatin (Primary) ; Zatolmilast (Primary)
- Indications Alzheimer's disease; Fragile X syndrome
- Focus Pharmacokinetics
- Sponsors Shionogi
Most Recent Events
- 29 Jun 2025 Planned initiation date changed from 9 Jun 2025 to 1 Jun 2025.
- 13 Jun 2025 New trial record